Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer

INTRODUCTION: The purpose of this investigation was to evaluate the efficacy of cisplatin chemotherapy in BRCA1 mutation carriers with metastatic breast cancer. METHODS: In a phase II, open-label study, 20 patients with metastatic breast cancer who carried a mutation in BRCA1 were treated with cispl...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Byrski, Tomasz, Dent, Rebecca, Blecharz, Pawel, Foszczynska-Kloda, Malgorzata, Gronwald, Jacek, Huzarski, Tomasz, Cybulski, Cezary, Marczyk, Elzbieta, Chrzan, Robert, Eisen, Andrea, Lubinski, Jan, Narod, Steven A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3680929/
https://ncbi.nlm.nih.gov/pubmed/22817698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3231
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak